Hong Kong stock unusual movement | hutchmed (china) (00013) rose nearly 6%, the combination therapy of Tauri and Vori shows a clinically significant response rate.
hutchmed (china) (00013) rose nearly 6%, as of the time of publication, up 5.92%, at 32.2 Hong Kong dollars, with a turnover of 54.3401 million Hong Kong dollars.
Top Research Reports for AstraZeneca, Accenture & AT&T
Hutchmed, AstraZeneca's Lung Cancer Combo Shrinks Tumors in Mid-stage Study
AstraZeneca Hits 4-week High
AstraZeneca Advances Science of Infectious Disease Protection at IDWeek 2024
GSK Says Depemokimab For Chronic Rhinosinusitis Reduces Nasal Polyp Size, Nasal Obstruction Versus Placebo At One Year
![Chinese Stocks Surge on Return from Holidays as Euphoria Extends [CSOP Global Market Morning Report]](https://ussnsimg.moomoo.com/sns_client_feed/71451441/20241008/1728367312428-c514003b5c.jpeg/thumb?area=999&is_public=true)
